Vanikieti Kavin, Poonyathalang Anuchit, Jindahra Panitha, Bouzika Peggy, Rizzo Joseph F, Cestari Dean M
Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Bangkok 10400, Thailand; Department of Ophthalmology, Harvard Medical School and the Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, United States.
Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Bangkok 10400, Thailand.
Mult Scler Relat Disord. 2017 Oct;17:87-91. doi: 10.1016/j.msard.2017.07.013. Epub 2017 Jul 10.
Neuromyelitis optica spectrum disorder (NMOSD) occurs more commonly in Asian than Caucasian populations. Few studies have examined the clinical features and visual outcome of optic neuritis (ON) within NMOSD in different racial populations. The objective of this study was to compare the clinical characteristics and long-term visual outcome of a Thai and an American-Caucasian cohort with NMOSD-related ON.
Medical records including brain and orbital magnetic resonance imaging (MRI) of 16 consecutive subjects who developed visual loss due to ON as part of NMOSD evaluated at a single American tertiary referral center between 2006 and 2015 were reviewed and compared to those of 16 consecutive similar subjects evaluated at a single Thai tertiary referral center between 2010 and 2016. These cohorts represented the total number of NMOSD-related ON subjects seen during that time at those institutions. Statistical analyses were used for continuous and categorical data sets, and multiple regression analysis was used to adjust for differences in duration of follow-up and number of episodes of ON in each affected eye.
All subjects within the Thai cohort were Asian, while the American cohort initially consisted of 14 Caucasian, 1 Asian and 1 African-American subject, but the latter two were excluded from analysis. In the Thai cohort, ON occurred in 21 eyes, with a total of 19 episodes, while in the American-Caucasian cohort ON occurred in 22 eyes, with a total of 21 episodes. Aquaporin 4 (AQP4)-antibody was positive in all subjects except for one American-Caucasian subject. The mean follow-up time was 17.8 (± 16.0) and 52.8 (± 51.9) months for the Thai and American-Caucasian populations, respectively. There was no difference between the two cohorts with respect to gender, age of NMOSD and NMOSD-related ON onset, initial clinical presentation of NMOSD, initial visual acuity and automated visual fields, prevalence of swollen optic disc in the acute phase, presence of pain on the affected side, mean time of onset of ON symptoms to MRI examination, distribution of segmental involvement of the anterior visual pathway abnormalities based on MRI findings, mean time of onset of ON symptoms to treatment, final visual acuity and automated visual fields. However, a higher proportion of Thai affected eyes were found to have an initial visual acuity of 20/200 or worse compared with the American-Caucasian cohort. Azathioprine was the most common maintenance treatment (75%) used among Thai subjects in contrast to rituximab (78.6%) among American-Caucasian subjects.
Despite the different prevalence among Thai and American-Caucasian populations, the clinical characteristics of ON in the NMOSD were very similar across these two populations, other than for more severe visual loss initially among Thai subjects. Notably, long-term visual outcome did not differ between these cohorts despite significant difference in the maintenance treatment regimen. This study did not assess neurological status or outcome.
视神经脊髓炎谱系障碍(NMOSD)在亚洲人群中的发病率高于白种人群。很少有研究探讨不同种族人群中NMOSD相关视神经炎(ON)的临床特征和视觉预后。本研究的目的是比较泰国和美国白种人队列中NMOSD相关ON的临床特征和长期视觉预后。
回顾了2006年至2015年期间在一家美国三级转诊中心评估的16例因ON导致视力丧失作为NMOSD一部分的连续受试者的病历,包括脑部和眼眶磁共振成像(MRI),并与2010年至2016年期间在一家泰国三级转诊中心评估的16例连续类似受试者的病历进行比较。这些队列代表了当时在这些机构中见到的NMOSD相关ON受试者的总数。对连续和分类数据集进行统计分析,并使用多元回归分析来调整随访时间和每只患眼ON发作次数的差异。
泰国队列中的所有受试者均为亚洲人,而美国队列最初由14名白种人、1名亚洲人和1名非裔美国人组成,但后两人被排除在分析之外。在泰国队列中,21只眼发生ON,共19次发作,而在美国白种人队列中,22只眼发生ON,共21次发作。除一名美国白种人受试者外,所有受试者水通道蛋白4(AQP4)抗体均为阳性。泰国和美国白种人队列的平均随访时间分别为17.8(±16.0)个月和52.8(±51.9)个月。在性别、NMOSD和NMOSD相关ON发病年龄、NMOSD的初始临床表现、初始视力和自动视野、急性期视盘肿胀的患病率、患侧疼痛的存在、ON症状发作至MRI检查的平均时间、基于MRI结果的前视觉通路异常节段性受累分布、ON症状发作至治疗的平均时间、最终视力和自动视野方面,两个队列之间没有差异。然而,与美国白种人队列相比,发现泰国患眼中初始视力为≤20/200的比例更高。硫唑嘌呤是泰国受试者中最常用的维持治疗药物(75%),而美国白种人受试者中最常用的是利妥昔单抗(78.6%)。
尽管泰国和美国白种人队列中的患病率不同,但NMOSD中ON的临床特征在这两个人群中非常相似,只是泰国受试者最初的视力丧失更严重。值得注意的是,尽管维持治疗方案存在显著差异,但这些队列的长期视觉预后并无差异。本研究未评估神经状态或预后。